Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Prenatal Viral Exposure May Cause Type 1 Diabetes

By LabMedica International staff writers
Posted on 22 Oct 2014
Women who contract a viral infection during pregnancy transmit viruses to their genetically susceptible fetuses, sparking the development of type 1 diabetes. More...


The incidence of type 1childhood diabetes has been increasing rapidly worldwide and if blood sugar levels are not well-controlled, juvenile diabetes can affect nearly every organ of a child's body with long-term complications of the disease developing gradually that may become disabling and even life-threatening.

Scientists at the Tel Aviv University Sackler Faculty of Medicine (Tel Aviv, Israel) and their colleagues conducted blood tests of 107 healthy pregnant women, testing for islet cell autoantibodies which are evidence of diabetes that appears years before the initial symptoms. Maternal and cord blood sera from the pregnant women were tested for islet cell autoantibodies using radioligand binding assays and for anti-Rotavirus and anti-Coxsackievirus B3 (CoxB3) antibody using an enzyme-linked immunosorbent assay during different seasons.

The scientists found a striking difference between women tested in different seasons, suggesting a link to winter epidemics. The concurrent presence of glutamic acid decarboxylase (GAD65) antibodies in cord blood and their mothers indicated autoimmune damage to islet cells during gestation, possibly caused by cross-placental transmission of viral infections and/or antivirus antibodies. In other words, during viral epidemics of winter months, 10% of the healthy pregnant women who had no family background of autoimmune diseases tested positive for damaging antibodies.

For 5, 22 and 17 pregnancies, antibodies to GAD65, Rotavirus and CoxB3, respectively, were detected in cord blood only and not in the corresponding maternal serum. In 10 pregnancies, Rotavirus antibody titers in the cord blood exceeded those in the corresponding maternal serum by 2.5 to 5-fold. Increased antibody titers after the 20th week of gestation suggested CoxB3 infection in one of the 20 pregnancies and Rotavirus in another.

Zvi Laron, MD, professor emeritus of pediatric endocrinology and senior author of the study said, “If our hypothesis can be verified, then preventive vaccine before conception would be useful in stopping the increasing incidence of type 1 diabetes and other autoimmune diseases. There is no cure for this diabetes, so true intervention would be important not only medically but also psychologically and financially, as the costs of the lifelong treatment of this chronic disease and other autoimmune diseases are great.” The study was published in the June 2014 issue of the journal Diabetic Medicine.

Related Links:

Sackler Faculty of Medicine 



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.